AXGN

Axogen Inc (AXGN)

Healthcare • NASDAQ$42.06-3.11%

Key Fundamentals
Symbol
AXGN
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices
Price
$42.06
Daily Change
-3.11%
Market Cap
$2.24B
Trailing P/E
N/A
Forward P/E
57.75
52W High
$45.83
52W Low
$9.22
Analyst Target
$50.78
Dividend Yield
N/A
Beta
1.17
About Axogen Inc

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; Avive+ Soft Tissue Matrix, a multi-layer amniotic membr

Company website

Research AXGN on Stk-Ai

Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.

Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.

Not financial advice. Terms · Privacy · ·

Loading...